Revance Therapeutics (RVNC) Appoints Erica Jordan as Chief Commercial Officer, Aesthetics

November 8, 2023 4:06 PM EST

Revance Therapeutics, Inc. (Nasdaq: RVNC) today announced the appointment of Erica Jordan, Senior Vice President of Commercial to Chief Commercial Officer (CCO), Aesthetics. As CCO, Erica will have global responsibility for all aesthetics commercial activity including commercial strategy, sales and marketing, branding, loyalty and engagement.

“Given the importance of the DAXXIFY® launch, I’m excited to elevate Erica to the position of Chief Commercial Officer, Aesthetics reporting directly to me. Having worked closely with Erica over the past several months, I have tremendous confidence in her abilities and leadership skills, and she’s been an invaluable partner as we’ve evolved our strategy based on customer feedback. In this role, Erica will not only help us drive the desired DAXXIFY adoption but also help ensure that we continue to grow our RHA® filler business and begin to realize the synergies of our portfolio,” said Mark J. Foley, Chief Executive Officer of Revance. “Erica joined us earlier this year and has a demonstrated track record as a global healthcare leader driving commercial transformation and growth, sales and marketing excellence, flagship product launches and operational efficiencies. Her extensive experience and strong ability to build partnerships both internally and externally, will be invaluable as we seek to maximize the market opportunity of our innovative products.”

“I’ve seen first-hand the tremendous excitement and potential that our product portfolio offers to the aesthetics market,” said Erica Jordan, Chief Commercial Officer, Aesthetics of Revance. “With key launch initiatives underway, I look forward to working with Mark and the rest of the team to continue to elevate Revance and its portfolio of products in the aesthetics marketplace. We will build on our progress, leverage learnings and partner with our current customers to continue to establish the value of DAXXIFY.”

Ms. Jordan joined Revance earlier this year as Senior Vice President of Commercial, bringing 25 years of marketing, sales management, commercial strategy, commercial operations and management experience at leading global healthcare companies. Prior to joining Revance, she served as President of the Metrex division at Envista Holdings, where she developed and executed a successful commercial strategy and implemented operational efficiencies to support double-digital growth. There, she also held the role of Senior Vice President, Sales & Marketing for the Ormco division where she successfully launched multiple new products and enabled significant market share growth for the flagship product categories. Before Envista Holdings, Ms. Jordan served as Vice President, Global Marketing for Change Healthcare where she developed and executed the commercial strategy for the first-ever cloud-based radiology enterprise imaging platform. She has held several marketing, commercial and operational leadership roles at Phillips Healthcare, including her role as Vice President, Senior General Manager, where she built the commercial team and the go-to-market strategy for the newly acquired women’s healthcare business. In addition, she held senior leadership roles at Fujifilm Medical Systems, Siemens Medical Solutions and GE Healthcare.

Ms. Jordan received her B.S. in Marketing and Finance from the University of Wisconsin-Milwaukee and is an active member of the Women Business Leaders of the US Health Care Industry Foundation.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Corporate News, Management Changes

Related Entities

Definitive Agreement